Application Value of NT-proBNP Combined with NLR in Evaluation of Major Adverse Cardiac Events in Elderly Patients with Chronic Heart Failure

Objective. To explore the application value of N-terminal pro-B type natriuretic peptide (NT-proBNP) combined with neutrophil-to-lymphocyte ratio (NLR) in evaluation of major adverse cardiac events (MACEs) in elderly patients with chronic heart failure (CHF). Methods. 50 CHF patients admitted to the...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhiyong Li, Hui Rong, Wenxun Wu, Ting Huang, Jun Xu
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Emergency Medicine International
Online Access:http://dx.doi.org/10.1155/2022/3689445
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562382188052480
author Zhiyong Li
Hui Rong
Wenxun Wu
Ting Huang
Jun Xu
author_facet Zhiyong Li
Hui Rong
Wenxun Wu
Ting Huang
Jun Xu
author_sort Zhiyong Li
collection DOAJ
description Objective. To explore the application value of N-terminal pro-B type natriuretic peptide (NT-proBNP) combined with neutrophil-to-lymphocyte ratio (NLR) in evaluation of major adverse cardiac events (MACEs) in elderly patients with chronic heart failure (CHF). Methods. 50 CHF patients admitted to the Department of Cardiovascular Medicine of our hospital from January 2021 to December 2021 were selected as the observation group. Another 50 non-CHF patients of our hospital were selected as the control group. Clinical data were collected from subjects who met the inclusion criteria, including general information, personal disease history, and laboratory test indicators. Patients with CHF were followed up for 6 months. Patients with CHF were divided into two groups, MACE group and non-MACE group. Results. The levels of WBC, NEU, NLR, and NT-proBNP in observation group were higher than those in control group, but the level of LYM was the opposite (P<0.05). The age, WBC, NEU, LYM, PLT, blood glucose, NLR, and NT-proBNP of MACE group and non-MACE group were significantly different (P<0.05). The increased levels of NEU, NLR, NT-proBNP and the decreased levels of LYM and PLT are all independent risk factors for MACE in elderly patients with CHF (P<0.05). The AUC of NLR in evaluating the occurrence of MACE in elderly CHF patients was 0.841. When the Youden index was 0.7692, the sensitivity was 76.92% and the specificity was 100.00%. The AUC of NT-proBNP in evaluating the occurrence of MACE in elderly CHF patients was 0.705. When the Youden index was 0.5260, the sensitivity was 76.92% and the specificity was 75.68%. The AUC of NT-proBNP combined with NLR in evaluating the occurrence of MACE in elderly CHF patients was 0.954. When the Youden index was 0.8420, the sensitivity was 92.31% and the specificity was 91.89%. Conclusion. NT-proBNP combined with NLR has high value in the evaluation of MACE in elderly CHF patients and can be used as an auxiliary predictive index in clinic.
format Article
id doaj-art-13f406d92cef4820a9e67f477d037d3a
institution Kabale University
issn 2090-2859
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Emergency Medicine International
spelling doaj-art-13f406d92cef4820a9e67f477d037d3a2025-02-03T01:22:41ZengWileyEmergency Medicine International2090-28592022-01-01202210.1155/2022/3689445Application Value of NT-proBNP Combined with NLR in Evaluation of Major Adverse Cardiac Events in Elderly Patients with Chronic Heart FailureZhiyong Li0Hui Rong1Wenxun Wu2Ting Huang3Jun Xu4Department of GeriatricsDepartment of Internal Medicine-CardiovascularClinical LaboratoryDepartment of HematologyDepartment of GeriatricsObjective. To explore the application value of N-terminal pro-B type natriuretic peptide (NT-proBNP) combined with neutrophil-to-lymphocyte ratio (NLR) in evaluation of major adverse cardiac events (MACEs) in elderly patients with chronic heart failure (CHF). Methods. 50 CHF patients admitted to the Department of Cardiovascular Medicine of our hospital from January 2021 to December 2021 were selected as the observation group. Another 50 non-CHF patients of our hospital were selected as the control group. Clinical data were collected from subjects who met the inclusion criteria, including general information, personal disease history, and laboratory test indicators. Patients with CHF were followed up for 6 months. Patients with CHF were divided into two groups, MACE group and non-MACE group. Results. The levels of WBC, NEU, NLR, and NT-proBNP in observation group were higher than those in control group, but the level of LYM was the opposite (P<0.05). The age, WBC, NEU, LYM, PLT, blood glucose, NLR, and NT-proBNP of MACE group and non-MACE group were significantly different (P<0.05). The increased levels of NEU, NLR, NT-proBNP and the decreased levels of LYM and PLT are all independent risk factors for MACE in elderly patients with CHF (P<0.05). The AUC of NLR in evaluating the occurrence of MACE in elderly CHF patients was 0.841. When the Youden index was 0.7692, the sensitivity was 76.92% and the specificity was 100.00%. The AUC of NT-proBNP in evaluating the occurrence of MACE in elderly CHF patients was 0.705. When the Youden index was 0.5260, the sensitivity was 76.92% and the specificity was 75.68%. The AUC of NT-proBNP combined with NLR in evaluating the occurrence of MACE in elderly CHF patients was 0.954. When the Youden index was 0.8420, the sensitivity was 92.31% and the specificity was 91.89%. Conclusion. NT-proBNP combined with NLR has high value in the evaluation of MACE in elderly CHF patients and can be used as an auxiliary predictive index in clinic.http://dx.doi.org/10.1155/2022/3689445
spellingShingle Zhiyong Li
Hui Rong
Wenxun Wu
Ting Huang
Jun Xu
Application Value of NT-proBNP Combined with NLR in Evaluation of Major Adverse Cardiac Events in Elderly Patients with Chronic Heart Failure
Emergency Medicine International
title Application Value of NT-proBNP Combined with NLR in Evaluation of Major Adverse Cardiac Events in Elderly Patients with Chronic Heart Failure
title_full Application Value of NT-proBNP Combined with NLR in Evaluation of Major Adverse Cardiac Events in Elderly Patients with Chronic Heart Failure
title_fullStr Application Value of NT-proBNP Combined with NLR in Evaluation of Major Adverse Cardiac Events in Elderly Patients with Chronic Heart Failure
title_full_unstemmed Application Value of NT-proBNP Combined with NLR in Evaluation of Major Adverse Cardiac Events in Elderly Patients with Chronic Heart Failure
title_short Application Value of NT-proBNP Combined with NLR in Evaluation of Major Adverse Cardiac Events in Elderly Patients with Chronic Heart Failure
title_sort application value of nt probnp combined with nlr in evaluation of major adverse cardiac events in elderly patients with chronic heart failure
url http://dx.doi.org/10.1155/2022/3689445
work_keys_str_mv AT zhiyongli applicationvalueofntprobnpcombinedwithnlrinevaluationofmajoradversecardiaceventsinelderlypatientswithchronicheartfailure
AT huirong applicationvalueofntprobnpcombinedwithnlrinevaluationofmajoradversecardiaceventsinelderlypatientswithchronicheartfailure
AT wenxunwu applicationvalueofntprobnpcombinedwithnlrinevaluationofmajoradversecardiaceventsinelderlypatientswithchronicheartfailure
AT tinghuang applicationvalueofntprobnpcombinedwithnlrinevaluationofmajoradversecardiaceventsinelderlypatientswithchronicheartfailure
AT junxu applicationvalueofntprobnpcombinedwithnlrinevaluationofmajoradversecardiaceventsinelderlypatientswithchronicheartfailure